Founded in 2003, PharmaNutra S.p.A. specializes in the development of innovative nutritional supplements and medical devices. The company's flagship product line, SiderAL, accounts for the majority of its revenue and is a market leader in oral iron supplements. PharmaNutra also produces the Cetilar brand, a line of topical medical devices designed for muscle and joint rehabilitation, and Apportal, a comprehensive nutritional supplement. The company operates through a direct network of pharmaceutical representatives in Italy and partners with distributors in over 70 countries worldwide. In addition to its core nutraceutical business, PharmaNutra expanded its scientific capabilities with the 2022 acquisition of Akern S.r.l., a specialist in bioelectrical impedance analysis.
